-
Signature
-
/s/ Marina A. Breed, as attorney-in-fact
-
Issuer symbol
-
AMT
-
Transactions as of
-
04 Mar 2026
-
Net transactions value
-
-$6,309,967
-
Form type
-
4
-
Filing time
-
06 Mar 2026, 16:23:06 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Vondran Steven O |
President and CEO, Director |
222 BERKELEY STREET, BOSTON |
/s/ Marina A. Breed, as attorney-in-fact |
06 Mar 2026 |
0001749304 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AMT |
Common Stock |
Options Exercise |
|
+33,482 |
+32% |
$94.71* |
138,856 |
04 Mar 2026 |
Direct |
|
| transaction |
AMT |
Common Stock |
Sale |
$2,834,284 |
-15,084 |
-11% |
$187.90 |
123,772 |
04 Mar 2026 |
Direct |
F1, F2 |
| transaction |
AMT |
Common Stock |
Sale |
$3,139,132 |
-16,625 |
-13% |
$188.82 |
107,147 |
04 Mar 2026 |
Direct |
F1, F3 |
| transaction |
AMT |
Common Stock |
Sale |
$336,551 |
-1,773 |
-1.7% |
$189.82 |
105,374 |
04 Mar 2026 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AMT |
Option to Purchase Common Stock |
Options Exercise |
|
-33,482 |
-100% |
$0.000000* |
0 |
04 Mar 2026 |
Common Stock |
33,482 |
$94.71 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: